[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-detail-125813-en":3,"doc-seo-125813-105":30,"detail-sidebar-cat-0-en-105":91},{"code":4,"msg":5,"data":6},0,"success",{"doc_id":7,"user_id":8,"nickname":9,"user_avatar":10,"doc_module":4,"category_id":11,"category_name":12,"doc_title":13,"doc_description":14,"doc_content":15,"file_id":16,"file_url":17,"file_type":18,"file_size":19,"view_count":4,"is_deleted":4,"is_public":20,"is_downloadable":20,"audit_status":20,"page_count":21,"language":22,"language_code":23,"site_id":24,"html_lang":23,"table_of_contents":25,"faqs":26,"seo_title":27,"seo_description":14,"update_tm":28,"read_time":29},125813,4398048949847,"Eliana","https://ap-avatar.wpscdn.com/avatar/400002536579ef2da7f?_k=1778318612642679267",8,"Research & Report","Label-free liquid biopsy - through the identification of tumor cells by machine learning-powered tomographic phase imaging flow cytometry","Image-based identification of circulating tumor cells in microfluidic cytometry remains a difficult liquid biopsy challenge. A machine learning–powered tomographic phase imaging flow cytometry system is presented to generate high-throughput 3D phase-contrast tomograms of individual cells. A hierarchical decision framework uses refractive-index features from 3D tomograms to distinguish tumor cells from white blood cells and to recognize tumor type. Proof-of-concept experiments use neuroblastoma and ovarian cancer cells versus monocytes.","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nLabel‑free liquid biopsy  \nthrough the identification of tumor cells by machine learning‑powered tomographic phase imaging flow cytometry  \nDaniele Pirone1, Annalaura Montella2,3, Daniele G. Sirico1, Martina Mugnano4, Massimiliano M. Villone4, Vittorio Bianco1, Lisa Miccio1, Anna Maria Porcelli 5,6,7, Ivana Kurelac7,8, Mario Capasso2,3, Achille Iolascon2,3, Pier Luca Maffettone4, Pasquale Memmolo1* & Pietro Ferraro1*  \nImage‑based identification of circulating tumor cells in microfluidic cytometry condition is one of the most challenging perspectives in the Liquid Biopsy scenario. Here we show a machine learning‑ powered tomographic phase imaging flow cytometry system capable to provide high‑throughput 3D phase‑contrast tomograms of each single cell. In fact, we show that discrimination of tumor cells against white blood cells is potentially achievable with the aid of artificial intelligence in a label‑free flow‑cyto‑tomography method. We propose a hierarchical machine learning decision‑maker, working on a set of features calculated from the 3D tomograms of the cells’ refractive index. We prove that 3D morphological features are adequately distinctive to identify tumor cells versus the white blood cell background in the first stage and, moreover, in recognizing the tumor type at the second decision step. Proof‑of‑concept experiments are shown, in which two different tumor cell lines, namely neuroblastoma cancer cells and ovarian cancer cells, are used against monocytes. The reported results allow claiming the identification of tumor cells with a success rate higher than 97% and with an accuracy over 97% in discriminating between the two cancer cell types, thus opening in a near future the route to a new Liquid Biopsy tool for detecting and classifying circulating tumor cells in blood by stain‑free method.  \nThe early diagnosis of a tumor condition can be considered nowadays the holy grail in cancer research, as it is crucial for improving the efficacy of therapeutic treatments. To date, the golden standard method for cancer diagnosis is the tissue biopsy, that is an invasive test involving the extraction of the cancerous tissue to be further analyzed1. However, this procedure only reflects the situation in a single site of the tumor at a single time instant, thus limiting the understanding of the complex characterization of a patient’s tumor. Indeed, it has been demonstrated that various areas within the tumor can harbor different genomic profiles2. Moreover, it takes long and cumbersome protocols. In principle, since tumors shed parts of themselves into the circulatory system, it is possible to detect them by analyzing body fluids, such as blood and urine. This approach, known as Liquid Biopsy (LB)3–7, provides a relatively less invasive methodology for detecting disease-derived biomarkers from  \n1CNR-ISASI, Institute of Applied Sciences and Intelligent Systems “Eduardo Caianiello”, Via Campi Flegrei 34, 80078 Pozzuoli, Naples, Italy. 2CEINGE Advanced Biotechnologies, Naples, Italy. 3DMMBM, Department of Molecular Medicine and Medical Biotechnology, University of Naples “Federico II”, Naples, Italy. 4Department of Chemical, Materials and Production Engineering, DICMaPI, University of Naples “Federico II”, Piazzale Tecchio 80, 80125 Naples, Italy. 5Department of Pharmacy and Biotechnology (FABIT), University of Bologna, Bologna, Italy. 6Interdepartmental Centre for Industrial Research ‘Scienze Della Vita e Tecnologie per La Salute’, University of Bologna, Bologna, Italy. 7Centre for Applied Biomedical Research (CRBA), University of Bologna, Bologna, Italy. 8DIMEC, Department of Medical and Surgical Sciences, Centro di Studio e Ricerca Sulle Neoplasie (CSR) Ginecologiche, Alma Mater Studiorum-University of Bologna, 40138 Bologna, Italy. *email: pasquale.memmolo@ [isasi.cnr.it](isasi.cnr.it); [pietro.ferraro@cnr.it](pietro.ferraro@cnr.it)  \n[www. nat","cbCaijpmz9Te3aU7","https://ap.wps.com/l/cbCaijpmz9Te3aU7","pdf",2391581,1,13,"English","en",105,"# Label-free liquid biopsy\n## Machine learning tomographic phase imaging flow cytometry\n## Hierarchical decision-maker for tumor-cell identification\n## Proof-of-concept experiments and performance\n## Clinical motivation for liquid biopsy vs tissue biopsy\n## Liquid biopsy technologies and CTC detection approaches","[{\"question\":\"What problem does the presented work address in liquid biopsy?\",\"answer\":\"Identifying circulating tumor cells using image-based microfluidic cytometry is challenging, especially in a label-free context with complex cell backgrounds.\"},{\"question\":\"How does the system identify tumor cells without labels?\",\"answer\":\"It generates high-throughput 3D phase-contrast tomograms and uses a hierarchical machine learning decision-maker based on features calculated from each cell’s 3D refractive-index tomograms.\"},{\"question\":\"What experimental setup is used to validate the approach?\",\"answer\":\"Two tumor cell lines—neuroblastoma and ovarian cancer cells—are compared against monocytes, enabling discrimination between tumor cells and the white blood cell background.\"}]","Label-free liquid biopsy - through the identification of tumor cells by machine learning-powered tomographic phase imaging flow cytometry | PDF",1785901353,33,{"code":4,"msg":31,"data":32},"ok",{"site_id":24,"language":23,"slug":33,"title":13,"keywords":34,"description":14,"schema_data":35,"social_meta":86,"head_meta":88,"extra_data":90,"updated_unix":28},"label-free-liquid-biopsy-through-the-identification-of-tumor-cells-by-machine-learning-powered-tomographic-phase-imaging-flow-cytometry","",{"@graph":36,"@context":85},[37,54,68],{"@type":38,"itemListElement":39},"BreadcrumbList",[40,44,48,51],{"item":41,"name":42,"@type":43,"position":20},"https://docshare.wps.com","Home","ListItem",{"item":45,"name":46,"@type":43,"position":47},"https://docshare.wps.com/document/","Document",2,{"item":49,"name":12,"@type":43,"position":50},"https://docshare.wps.com/document/research-report/",3,{"item":52,"name":13,"@type":43,"position":53},"https://docshare.wps.com/document/label-free-liquid-biopsy-through-the-identification-of-tumor-cells-by-machine-learning-powered-tomographic-phase-imaging-flow-cytometry/125813/",4,{"url":52,"name":13,"@type":55,"author":56,"headline":13,"publisher":58,"fileFormat":61,"inLanguage":23,"description":14,"dateModified":62,"datePublished":62,"encodingFormat":61,"isAccessibleForFree":63,"interactionStatistic":64},"DigitalDocument",{"name":9,"@type":57},"Person",{"url":41,"name":59,"@type":60},"DocShare","Organization","application/pdf","2026-08-05",true,{"@type":65,"interactionType":66,"userInteractionCount":4},"InteractionCounter",{"@type":67},"ViewAction",{"@type":69,"mainEntity":70},"FAQPage",[71,77,81],{"name":72,"@type":73,"acceptedAnswer":74},"What problem does the presented work address in liquid biopsy?","Question",{"text":75,"@type":76},"Identifying circulating tumor cells using image-based microfluidic cytometry is challenging, especially in a label-free context with complex cell backgrounds.","Answer",{"name":78,"@type":73,"acceptedAnswer":79},"How does the system identify tumor cells without labels?",{"text":80,"@type":76},"It generates high-throughput 3D phase-contrast tomograms and uses a hierarchical machine learning decision-maker based on features calculated from each cell’s 3D refractive-index tomograms.",{"name":82,"@type":73,"acceptedAnswer":83},"What experimental setup is used to validate the approach?",{"text":84,"@type":76},"Two tumor cell lines—neuroblastoma and ovarian cancer cells—are compared against monocytes, enabling discrimination between tumor cells and the white blood cell background.","https://schema.org",{"og:url":52,"og:type":87,"og:title":13,"og:site_name":59,"og:description":14},"article",{"robots":89,"canonical":52},"index,follow",{"doc_id":7,"site_id":24},{"code":4,"msg":5,"data":92},[93,97,101,105,110,115,120,123,128,131,135],{"id":20,"doc_module":4,"doc_module_name":46,"category_name":94,"show_sort_weight":95,"slug":96},"Story & Novel",90,"story-novel",{"id":47,"doc_module":4,"doc_module_name":46,"category_name":98,"show_sort_weight":99,"slug":100},"Literature",80,"literature",{"id":53,"doc_module":4,"doc_module_name":46,"category_name":102,"show_sort_weight":103,"slug":104},"Exam",70,"exam",{"id":106,"doc_module":4,"doc_module_name":46,"category_name":107,"show_sort_weight":108,"slug":109},5,"Comic",60,"comic",{"id":111,"doc_module":4,"doc_module_name":46,"category_name":112,"show_sort_weight":113,"slug":114},6,"Technology",50,"technology",{"id":116,"doc_module":4,"doc_module_name":46,"category_name":117,"show_sort_weight":118,"slug":119},7,"Healthcare",40,"healthcare",{"id":11,"doc_module":4,"doc_module_name":46,"category_name":12,"show_sort_weight":121,"slug":122},30,"research-report",{"id":124,"doc_module":4,"doc_module_name":46,"category_name":125,"show_sort_weight":126,"slug":127},9,"Religion & Spirituality",20,"religion-spirituality",{"id":126,"doc_module":4,"doc_module_name":46,"category_name":129,"show_sort_weight":126,"slug":130},"World Cup","world-cup",{"id":132,"doc_module":4,"doc_module_name":46,"category_name":133,"show_sort_weight":132,"slug":134},10,"Lifestyle","lifestyle",{"id":136,"doc_module":4,"doc_module_name":46,"category_name":137,"show_sort_weight":106,"slug":138},19,"General","general"]